Literature DB >> 1655979

Interactions between the argininyl moieties of neurotensin and the catechol protons of dopamine.

J O Schenk1, M T Morocco, V A Ziemba.   

Abstract

The interaction between dopamine and neurotensin as well as other Arg-containing peptides was studied to provide more chemical details of how dopamine binds to the neuropeptide neurotensin. The stoichiometry of 1:1, dopamine to neurotensin, was confirmed by additional electroanalytical and ultraviolet-visible spectroscopic studies. By analyses of the 205- to 340-nm difference spectra of fixed concentrations of dopamine in the presence of increasing amounts of neurotensin, the dissociation constant of the interaction was found to be 5.9 x 10(-8) mol/L. This finding confirmed (by a second physical method) the previously reported KD value obtained by electroanalytical techniques. The associations between dopamine and neurotensin as well as the neurotensin fragment Pro7-Arg8-Arg9-Pro10 were found to be pH dependent when the dissociation constant was measured as a function of pH (in 150 mmol/L NaCl). The results of studies of the formal potential of dopamine in the presence of Arg and Arg-containing peptides confirmed that catechol protons are directly involved in the association and that the chemical species of dopamine associated with neurotensin is a catecholate form. The (pseudo)-first-order rate constant of dissociation of the complex at pH 7.6, measured by the chronoamperometric and rotating disk electroanalytical techniques, was found to be approximately 10(5) s-1, indicating that the rate of formation of the complex is under diffusion control. A hypothetical chemical structure of the neurotensin-dopamine complex is suggested.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655979     DOI: 10.1111/j.1471-4159.1991.tb06382.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  Natural electrophoresis of norepinephrine and ascorbic acid.

Authors:  P F Dillon; R S Root-Bernstein; P R Sears; L K Olson
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

2.  Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex.

Authors:  R Fernández; R Sabater; J A Sáez; R Montes; F Alba; J M Ferrer
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 3.  Survey on the pharmacodynamics of the new antipsychotic risperidone.

Authors:  A A Megens; F H Awouters; A Schotte; T F Meert; C Dugovic; C J Niemegeers; J E Leysen
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

4.  Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

Authors:  J E Leysen; P M Janssen; A Schotte; W H Luyten; A A Megens
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.